Cargando…
Evaluation of Choroidal Vascularity Index in Keratoconus Patients: Does Choroidal Vascularity Change in Keratoconus?
PURPOSE: To investigate the choroidal structure in keratoconic patients with different severity using the choroidal vascularity index (CVI) derived from image binarization on enhanced depth imaging optical coherence tomography scans (EDI-OCT). METHODS: Sixty-eight eyes from 34 keratoconus (KCN) pati...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481970/ https://www.ncbi.nlm.nih.gov/pubmed/37680286 http://dx.doi.org/10.4103/joco.joco_189_22 |
Sumario: | PURPOSE: To investigate the choroidal structure in keratoconic patients with different severity using the choroidal vascularity index (CVI) derived from image binarization on enhanced depth imaging optical coherence tomography scans (EDI-OCT). METHODS: Sixty-eight eyes from 34 keratoconus (KCN) patients and 72 eyes from 36 healthy subjects were recruited in this prospective, noninterventional, comparative cross-sectional study. EDI-OCT was employed to measure choroidal parameters, including choroidal thickness (CT), total choroidal area (TCA), luminal area, stromal area, and CVI. RESULTS: Subfoveal CT was 354.6 ± 66.8 μm in the control group and 371 ± 64.5 μm in the KCN group (P = 0.86). There was no significant difference between control and KCN groups in terms of TCA (0.66 ± 0.14 mm(2) vs. 0.7 ± 0.12 mm(2); P = 0.70), luminal area (0.49 ± 0.10 mm(2) vs. 0.53 ± 0.08 mm(2); P = 0.67), and stromal area (0.16 ± 0.05 mm(2) vs. 0.17 ± 0.05 mm(2); P = 0.84). CVI was also comparable in the control group (75.4% ±3.4%) and the KCN group (75.6% ±4.5%; P = 0.43). There was also no significant correlation between other choroidal parameters and KCN severity indices. CONCLUSION: It seems that CVI as well as other choroidal biomarkers were not significantly different between patients with KCN and healthy subjects. |
---|